Literature DB >> 29743366

Regulation of Virus-Associated Lymphoma Growth and Gene Expression by Bacterial Quorum-Sensing Molecules.

Jing Qiao1, Yueyu Cao1, Jovanny Zabaleta2, Liang Yang3, Lu Dai4,5, Zhiqiang Qin4,5.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) can cause several human cancers, including primary effusion lymphoma (PEL), which frequently occur in immunocompromised patients. KSHV-infected patients often suffer from polymicrobial infections caused by opportunistic bacterial pathogens. Therefore, it is crucial to understand how these coinfecting microorganisms or their secreted metabolites may affect KSHV infection and the pathogenesis of virus-associated malignancies. Quorum sensing (QS), a cell density-based intercellular communication system, employs extracellular diffusible signaling molecules to regulate bacterial virulence mechanisms in a wide range of bacterial pathogens, such as Pseudomonas aeruginosa, which is one of the most common opportunistic microorganisms found in immunocompromised individuals. In this study, we evaluated and compared the influence on PEL growth and the host/viral interactome of the major QS signaling molecules [N-(3-oxododecanoyl)-l-homoserine lactone (OdDHL), N-butyrylhomoserine lactone (BHL), and 2-heptyl-3-hydroxy-4-quinolone (PQS)] in conditioned medium from wild-type (wt) and QS mutant laboratory strains as well as clinical isolates of P. aeruginosa Our data indicate that P. aeruginosa coinfection may facilitate virus dissemination and establishment of new infection and further promote tumor development through effectively inducing viral lytic gene expression by its QS systems.IMPORTANCE Currently, most studies about KSHV infection and/or virus-associated malignancies depend on pure culture systems or immunodeficient animal models. However, the real situation should be much more complicated in KSHV-infected immunocompromised patients due to frequent polymicrobial infections. It is important to understand the interaction of KSHV and coinfecting microorganisms, especially opportunistic bacterial pathogens. Here we report for the first time that P. aeruginosa and its quorum-sensing signaling molecules display a complicated impact on KSHV-associated lymphoma growth as well as the intracellular host/viral gene expression profile. Our data imply that targeting of coinfecting pathogens is probably necessary during treatment of virus-associated malignancies in these immunocompromised patients.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  KSHV; Pseudomonas aeruginosa; primary effusion lymphoma; quorum sensing

Mesh:

Substances:

Year:  2018        PMID: 29743366      PMCID: PMC6026753          DOI: 10.1128/JVI.00478-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  The immune system vs. Pseudomonas aeruginosa biofilms.

Authors:  Peter Østrup Jensen; Michael Givskov; Thomas Bjarnsholt; Claus Moser
Journal:  FEMS Immunol Med Microbiol       Date:  2010-05-28

2.  Direct detection of N-acylhomoserine lactones in cystic fibrosis sputum.

Authors:  Barry Middleton; Helen C Rodgers; Miguel Cámara; Alan J Knox; Paul Williams; Andrea Hardman
Journal:  FEMS Microbiol Lett       Date:  2002-01-22       Impact factor: 2.742

3.  Autolysis and autoaggregation in Pseudomonas aeruginosa colony morphology mutants.

Authors:  David A D'Argenio; M Worth Calfee; Paul B Rainey; Everett C Pesci
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

4.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

Review 5.  Inter-kingdom signaling: chemical language between bacteria and host.

Authors:  Alline R Pacheco; Vanessa Sperandio
Journal:  Curr Opin Microbiol       Date:  2009-03-21       Impact factor: 7.934

6.  A bacterial cell to cell signal in the lungs of cystic fibrosis patients.

Authors:  David N Collier; Lisa Anderson; Susan L McKnight; Terry L Noah; Michael Knowles; Richard Boucher; Ute Schwab; Peter Gilligan; Everett C Pesci
Journal:  FEMS Microbiol Lett       Date:  2002-09-24       Impact factor: 2.742

7.  KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts.

Authors:  Zhiqiang Qin; Andrew Jakymiw; Victoria Findlay; Chris Parsons
Journal:  Int J Cell Biol       Date:  2012-02-19

Review 8.  KSHV miRNAs decrease expression of lytic genes in latently infected PEL and endothelial cells by targeting host transcription factors.

Authors:  Karlie Plaisance-Bonstaff; Hong Seok Choi; Tyler Beals; Brian J Krueger; Isaac W Boss; Lauren A Gay; Irina Haecker; Jianhong Hu; Rolf Renne
Journal:  Viruses       Date:  2014-10-23       Impact factor: 5.048

Review 9.  The Role of microRNAs in the Pathogenesis of Herpesvirus Infection.

Authors:  Diogo Piedade; José Miguel Azevedo-Pereira
Journal:  Viruses       Date:  2016-06-02       Impact factor: 5.048

10.  Lipoteichoic acid (LTA) and lipopolysaccharides (LPS) from periodontal pathogenic bacteria facilitate oncogenic herpesvirus infection within primary oral cells.

Authors:  Lu Dai; Michael R DeFee; Yueyu Cao; Jiling Wen; Xiaofei Wen; Mairi C Noverr; Zhiqiang Qin
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

View more
  3 in total

Review 1.  The Role of Bacteria in KSHV Infection and KSHV-Induced Cancers.

Authors:  Ashley Markazi; Wen Meng; Paige M Bracci; Michael S McGrath; Shou-Jiang Gao
Journal:  Cancers (Basel)       Date:  2021-08-25       Impact factor: 6.575

Review 2.  The Role of Pseudomonas aeruginosa Virulence Factors in Cytoskeletal Dysregulation and Lung Barrier Dysfunction.

Authors:  Brant M Wagener; Ruihan Hu; Songwei Wu; Jean-Francois Pittet; Qiang Ding; Pulin Che
Journal:  Toxins (Basel)       Date:  2021-11-02       Impact factor: 5.075

Review 3.  Regulation of KSHV Latency and Lytic Reactivation.

Authors:  Grant Broussard; Blossom Damania
Journal:  Viruses       Date:  2020-09-17       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.